Cite

    Tzellos, T., van Straalen, K. R., Kyrgidis, A., Alavi, A., Goldfarb, N., Gulliver, W., Jemec, G. B. E., Lowes, M. A., Marzano, A. V., Prens, E. P., Sayed, C. J., van der Zee, H. H., & Zouboulis, C. C. (2023). development and validation of IHS4‐55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology, 37, 395–401. http://access.bl.uk/ark:/81055/vdc_100173977526.0x000043